imatinib mesylate has been researched along with Becker Muscular Dystrophy in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bizario, JC; Cerri, DG; Costa, MC; de Araujo, DD; de Castro, FA; Fukuhara, PS; Nomizo, A; Oliveira, GL; Ribeiro, JC; Rodrigues, LC | 1 |
1 other study(ies) available for imatinib mesylate and Becker Muscular Dystrophy
| Article | Year |
|---|---|
Imatinib mesylate ameliorates the dystrophic phenotype in exercised mdx mice.
Topics: Animals; Benzamides; Creatine Kinase; Cytokines; Imatinib Mesylate; Male; Mice; Muscles; Muscular Dystrophy, Animal; Muscular Dystrophy, Duchenne; Physical Conditioning, Animal; Piperazines; Protein Kinase Inhibitors; Pyrimidines | 2009 |